rs104894821
Variant summary
Our verdict is Pathogenic. The variant received 17 ACMG points: 17P and 0B. PM1PM2PP2PP3_StrongPP5_Very_Strong
The NM_000166.6(GJB1):c.283G>A(p.Val95Met) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000166.6 missense
Scores
Clinical Significance
Conservation
Publications
- Charcot-Marie-Tooth disease X-linked dominant 1Inheritance: XL Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, PanelApp Australia, ClinGen, Labcorp Genetics (formerly Invitae)
- X-linked progressive cerebellar ataxiaInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 17 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000166.6. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GJB1 | NM_000166.6 | MANE Select | c.283G>A | p.Val95Met | missense | Exon 2 of 2 | NP_000157.1 | ||
| GJB1 | NM_001097642.3 | c.283G>A | p.Val95Met | missense | Exon 2 of 2 | NP_001091111.1 | |||
| GJB1 | NM_001440770.1 | c.283G>A | p.Val95Met | missense | Exon 3 of 3 | NP_001427699.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GJB1 | ENST00000361726.7 | TSL:1 MANE Select | c.283G>A | p.Val95Met | missense | Exon 2 of 2 | ENSP00000354900.6 | ||
| GJB1 | ENST00000374029.2 | TSL:5 | c.283G>A | p.Val95Met | missense | Exon 2 of 2 | ENSP00000363141.1 | ||
| GJB1 | ENST00000447581.2 | TSL:5 | c.283G>A | p.Val95Met | missense | Exon 3 of 3 | ENSP00000407223.2 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
Charcot-Marie-Tooth disease X-linked dominant 1 Pathogenic:4
The GJB1 c.283G>A; p.Val95Met variant (rs104894821) is reported in the literature in multiple individuals affected with X-linked Charcot-Marie-Tooth disease (Bone 1995, Kim 2017, Nam 2016, Montenegro 2011). This variant is reported in ClinVar (Variation ID: 10441), and is absent from general population databases (Exome Variant Server, Genome Aggregation Database), indicating it is not a common polymorphism. The valine at codon 95 is highly conserved, and computational analyses (SIFT, PolyPhen-2) predict that this variant is deleterious. Functional analyses of the variant protein show a significant defect in channel formation and function (Ressot 1998, Wang 2004). Based on available information, this variant is considered to be pathogenic. References: Bone LJ et al. New connexin32 mutations associated with X-linked Charcot-Marie-Tooth disease. Neurology. 1995 Oct;45(10):1863-6. Kim JK et al. X-linked Charcot-Marie-Tooth disease with GJB1 mutation presenting as acute disseminated encephalomyelitis-like illness: A case report. Medicine (Baltimore). 2017 Dec;96(49):e9176. Montenegro G et al. Exome sequencing allows for rapid gene identification in a Charcot-Marie-Tooth family. Ann Neurol. 2011 Mar;69(3):464-70. Nam SH et al. Identification of Genetic Causes of Inherited Peripheral Neuropathies by Targeted Gene Panel Sequencing. Mol Cells. 2016 May 31;39(5):382-8. Ressot C et al. Connexin32 mutations associated with X-linked Charcot-Marie-Tooth disease show two distinct behaviors: loss of function and altered gating properties. J Neurosci. 1998 Jun 1;18(11):4063-75. Wang HL et al. Functional analysis of connexin-32 mutants associated with X-linked dominant Charcot-Marie-Tooth disease. Neurobiol Dis. 2004 Mar;15(2):361-70.
PS3, PS4, PM2, PP3
not provided Pathogenic:3
Published functional studies demonstrate V95M prevents formation of functional channels (Ressot et al., 1998; Wang et al., 2004); Not observed at significant frequency in large population cohorts (gnomAD); Missense variants in this gene are often considered pathogenic (HGMD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 23649551, 27098783, 23293578, 9361298, 9401007, 10873293, 15006706, 7477983, 29245364, 27025386, 16922730, 17353473, 10751669, 12067629, 10093067, 10586261, 9592087, 21254193, 31827005, 32399692, 32376792)
Charcot-Marie-Tooth disease Pathogenic:1Uncertain:1
Inborn genetic diseases Pathogenic:1
The p.V95M variant (also known as c.283G>A), located in coding exon 1 of the GJB1 gene, results from a G to A substitution at nucleotide position 283. The valine at codon 95 is replaced by methionine, an amino acid with highly similar properties. This alteration has been detected in multiple individuals with Charcot-Marie-Tooth neuropathy X type 1 (CMTX1) (Volodarsky M et al. J Med Genet, 2021 04;58:284-288; Bone LJ et al. Neurology, 1995 Oct;45:1863-6; Hahn AF et al. Ann N Y Acad Sci, 1999 Sep;883:366-82; Dubourg O et al. Brain, 2001 Oct;124:1958-67; Liu X et al. Front Neurol, 2020 Jul;11:690; Kim JK et al. Medicine (Baltimore), 2017 Dec;96:e9176; Hong YB et al. J Peripher Nerv Syst, 2017 09;22:172-181; Sun B et al. J Peripher Nerv Syst, 2017 03;22:13-18; Shahrizaila N et al. Muscle Nerve, 2014 Feb;49:198-201; Montenegro G et al. Ann Neurol, 2011 Mar;69:464-70; Park HK et al. Clin Genet, 2006 Sep;70:253-6; Rouger H et al. Hum Mutat, 1997;10:443-52). Multiple functional assays show that V95M has reduced junctional conductance and diffusion of small molecules between cells in vitro (Wang HL et al. Neurobiol Dis, 2004 Mar;15:361-70; Ressot C et al. J Neurosci, 1998 Jun;18:4063-75). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic.
Charcot-Marie-Tooth Neuropathy X Pathogenic:1
This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 95 of the GJB1 protein (p.Val95Met). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with X-linked Charcot-Marie-Tooth (CMT) disease (PMID: 10586261, 10873293, 16922730, 21254193). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 10441). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt GJB1 protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects GJB1 function (PMID: 9592087, 21254193). For these reasons, this variant has been classified as Pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at